Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Eur J Cancer. 2020 May 24;134:41–51. doi: 10.1016/j.ejca.2020.04.024

Table 3.

Toxicity ≥ Grade 3 (CTCAE V 4.0) in Total Cohort

Toxicity Grade 3 Grade 4 Grade 5 Grade 3, 4 or 5 Total (N=297)
Biochemical 73a (24.6%)
Bilirubin 35 (11.8%) 4 (1.3%) 0
AST/ALT 41 (13.8%) 0 0
ALP 2(0.6%) 0 0
Gastrointestinal
Biliary 1 (0.3%) 1 (0.3%) 1 (0.3%) 3 (1.0%)
Luminal GI toxicity 3 (1.0%) 0 1 (0.3%) 4 (1.3%)
Liver
Ascites 23 (7.7%) 0 0 23 (7.7%)
Classic RILD 0 (0%)
CP score decline ≥ 2 at 3 months after SBRT 34 (15.9%)
ALBI Grade increase at 3 months after SBRT 51 (21.2%)

Toxicity reported includes acute and late toxicity at least possibly attributable to SBRT.

a

Some patients had more than one kind of biochemical toxicity.